Black Diamond Therapeutics, Inc. (Nasdaq:BDTX)

Health Care/Life Sciences • Pharmaceuticals

CIK 1701541

Company

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Address
One Main Street
14th floor
Cambridge, Massachusetts 02142

Employees
54

Stock Info

Close
$1.8600

Day Range
1.7800 - 1.8799

52 Week Range
1.7700 - 7.6600

Average volume
757.56K

Short Interest
7.72M (02/14/25)

% of Float Shorted
17.92%

Market Cap
$105.25M

Revenue
N/A

Net Income
-$82.44M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$1.3639

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman, President & Chief Executive Officer
Mark A. Velleca

Lead Independent Director
Samarth Kulkarni

Independent Director
Ali Behbahani

Independent Director
Garry E. Menzel

Independent Director
Shannon Campbell

Independent Director
Prakash Raman

Independent Director
Kapil Dhingra

SEC filings

Date	Form	Event
16 Dec, 2024	4
16 Dec, 2024	4
16 Dec, 2024	4
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G
8 Nov, 2024	SC 13G
5 Nov, 2024	10-Q
5 Nov, 2024	8-K
24 Oct, 2024	SC 13G
7 Oct, 2024	8-K
23 Sep, 2024	8-K
20 Sep, 2024	4
20 Sep, 2024	4
20 Sep, 2024	4
30 Aug, 2024	4
8 Aug, 2024	SC 13D/A
6 Aug, 2024	8-K
6 Aug, 2024	10-Q
31 Jul, 2024	144
26 Jul, 2024	144
16 Jul, 2024	144
11 Jul, 2024	144
10 Jul, 2024	SC 13G/A
9 Jul, 2024	144
28 Jun, 2024	144
27 Jun, 2024	144
26 Jun, 2024	144
24 Jun, 2024	144
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	144
20 Jun, 2024	144
20 Jun, 2024	144
18 Jun, 2024	144
14 Jun, 2024	144
13 Jun, 2024	144
12 Jun, 2024	144
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	8-K
13 May, 2024	SC 13D/A
9 May, 2024	SC 13D/A
9 May, 2024	10-Q
9 May, 2024	8-K
24 Apr, 2024	DEF 14A
24 Apr, 2024	ARS
24 Apr, 2024	DEFA14A
12 Apr, 2024	3
12 Apr, 2024	4
12 Apr, 2024	PRE 14A
12 Apr, 2024	3
12 Apr, 2024	4
11 Apr, 2024	8-K
3 Apr, 2024	4
3 Apr, 2024	4
12 Mar, 2024	10-K
12 Mar, 2024	8-K
12 Mar, 2024	S-8
11 Mar, 2024	SC 13G/A
15 Feb, 2024	4
15 Feb, 2024	4
15 Feb, 2024	4
15 Feb, 2024	4
15 Feb, 2024	4
15 Feb, 2024	4
14 Feb, 2024	SC 13G
13 Feb, 2024	SC 13G/A
18 Jan, 2024	8-K
4 Jan, 2024	8-K
15 Dec, 2023	4
15 Dec, 2023	4
13 Dec, 2023	8-K
9 Nov, 2023	SC 13D/A
6 Nov, 2023	8-K
6 Nov, 2023	10-Q
19 Oct, 2023	4
18 Sep, 2023	4
18 Sep, 2023	4
18 Sep, 2023	8-K	CEO Change
18 Sep, 2023	4
11 Aug, 2023	10-Q
11 Aug, 2023	8-K
7 Jul, 2023	4
6 Jul, 2023	4
3 Jul, 2023	4
30 Jun, 2023	8-K
30 Jun, 2023	424B5
29 Jun, 2023	424B5
29 Jun, 2023	4
28 Jun, 2023	4
27 Jun, 2023	8-K
27 Jun, 2023	144
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
16 May, 2023	8-K
9 May, 2023	10-Q
9 May, 2023	8-K
4 Apr, 2023	ARS
4 Apr, 2023	DEFA14A
4 Apr, 2023	DEF 14A
20 Mar, 2023	4
20 Mar, 2023	4
20 Mar, 2023	4
9 Mar, 2023	S-8
9 Mar, 2023	8-K
9 Mar, 2023	10-K
15 Feb, 2023	4
15 Feb, 2023	4
15 Feb, 2023	4
15 Feb, 2023	4
15 Feb, 2023	4
15 Feb, 2023	4
14 Feb, 2023	SC 13G/A
23 Dec, 2022	4
19 Dec, 2022	4
19 Dec, 2022	4
19 Dec, 2022	4
19 Dec, 2022	8-K
19 Dec, 2022	4
12 Dec, 2022	8-K
22 Nov, 2022	EFFECT
18 Nov, 2022	CORRESP
17 Nov, 2022	UPLOAD
14 Nov, 2022	S-3
8 Nov, 2022	8-K
8 Nov, 2022	10-Q
2 Nov, 2022	4
31 Oct, 2022	4
25 Oct, 2022	4
21 Oct, 2022	4
19 Sep, 2022	4
19 Sep, 2022	4
19 Sep, 2022	4
19 Sep, 2022	4
9 Aug, 2022	8-K
9 Aug, 2022	10-Q
8 Jul, 2022	SC 13G
30 Jun, 2022	4/A
30 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
15 Jun, 2022	3
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
13 Jun, 2022	4
7 Jun, 2022	8-K
11 May, 2022	8-K
11 May, 2022	10-Q
29 Apr, 2022	4
28 Apr, 2022	DEFA14A
28 Apr, 2022	DEF 14A
25 Apr, 2022	8-K
20 Apr, 2022	4
14 Apr, 2022	4
14 Apr, 2022	SC 13G/A
13 Apr, 2022	3
7 Apr, 2022	3
7 Apr, 2022	4
7 Apr, 2022	8-K
18 Mar, 2022	4
18 Mar, 2022	4
18 Mar, 2022	4
17 Mar, 2022	8-K
17 Mar, 2022	10-K
17 Mar, 2022	S-8
17 Feb, 2022	4
17 Feb, 2022	4
17 Feb, 2022	4
17 Feb, 2022	4
17 Feb, 2022	4
11 Feb, 2022	SC 13G/A
9 Feb, 2022	SC 13G/A
4 Feb, 2022	SC 13G
10 Jan, 2022	8-K
10 Jan, 2022	8-K
17 Dec, 2021	4
17 Dec, 2021	4
29 Nov, 2021	3
29 Nov, 2021	3
22 Nov, 2021	8-K
8 Nov, 2021	10-Q
8 Nov, 2021	8-K
23 Sep, 2021	4
23 Sep, 2021	4
17 Sep, 2021	3
12 Aug, 2021	8-K
12 Aug, 2021	10-Q
11 Aug, 2021	3
11 Aug, 2021	4
10 Aug, 2021	8-K
5 Aug, 2021	8-K	CEO Change
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	4
22 Jun, 2021	8-K
21 May, 2021	4
19 May, 2021	8-K
13 May, 2021	4
7 May, 2021	10-Q
7 May, 2021	8-K
5 May, 2021	4
29 Apr, 2021	DEFA14A
27 Apr, 2021	DEF 14A
23 Apr, 2021	4
23 Apr, 2021	4
21 Apr, 2021	8-K
13 Apr, 2021	4
7 Apr, 2021	4
5 Apr, 2021	4
25 Mar, 2021	S-8
25 Mar, 2021	8-K
25 Mar, 2021	10-K
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
16 Mar, 2021	4
15 Mar, 2021	8-K
4 Mar, 2021	4
19 Feb, 2021	4
19 Feb, 2021	4
19 Feb, 2021	4
19 Feb, 2021	4
19 Feb, 2021	4
12 Feb, 2021	4
11 Feb, 2021	SC 13G
10 Feb, 2021	SC 13G
4 Feb, 2021	4
1 Feb, 2021	8-K
1 Feb, 2021	S-3ASR
22 Jan, 2021	4
22 Jan, 2021	3
20 Jan, 2021	8-K
14 Jan, 2021	4
11 Jan, 2021	4
6 Jan, 2021	4
6 Jan, 2021	4

Last update:2025-03-06 13:14:53.605428

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.